|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0763 EUR | +2.83% |
|
+5.83% | +17.02% |
| Mar. 09 | TME Pharma Secures 12-month Loan Extension | MT |
| Jan. 05 | TME Pharma N.V. Provides Update on Its Activities | CI |
Executive Committee: TME Pharma N.V.
| Manager | Positions heldSince | ||||
|---|---|---|---|---|---|
![Diede van den Ouden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>) Diede van den Ouden |
| ||||
Aram Andrew Mangasarian 56 year |
| ||||
Jarl Ulf Birger Jungnelius 75 year |
| ||||
Ewelina Staniuk |
| ||||
Karen Ophoff |
|
Composition of the Board of Directors: TME Pharma N.V.
| Director | CommitteesSince | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Maurizio PetitBon 78 year |
| ||||||||
Susan Coles 60 year |
| ||||||||
Diede van den Ouden |
| ||||||||
Lee Schalop |
|
Latest Appointments: TME Pharma N.V.
Former Officers and Directors: TME Pharma N.V.
| Insider | Positions held SinceUntil | ||||||
|---|---|---|---|---|---|---|---|
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
|
Age distribution of managers
Parity Men Women
| Male | 5 |
|---|---|
| Female | 3 |
Of which Executive Committee
| Male | 3 |
|---|---|
| Female | 2 |
Of which Directors
| Male | 3 |
|---|---|
| Female | 1 |
Departures of Key Persons
Chairman
2017-09-29 2019-05-02
Chairman
- 2019-06-24
Select your edition
All financial news and data tailored to specific country editions
